Millie Fox

Years Active: 2022-2022
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Shanade Dunn, Cath Eberlein, Jason Yu, Albert Gris-Oliver, Swee Hoe Ong, Urs Yelland, Natalie Cureton, Anna Staniszewska, Robert McEwen, Millie Fox, James Pilling, Philip Hopcroft, Elizabeth A Coker, Patricia Jaaks, Mathew J Garnett, Beverley Isherwood, Violeta Serra, Barry R Davies, Simon T Barry, James T Lynch, Kosuke Yusa
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors. Oncogene 41 (46) (2022)

Millie Fox.css-eqlu8i{font-size:small;padding-left:4px;}